stocks logo

ASPN Valuation

Aspen Aerogels Inc
$
3.860
-0.25(-6.083%)1D

ASPN Relative Valuation

ASPN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ASPN is overvalued; if below, it's undervalued.
AI Stock Picker

Historical Valuation

Aspen Aerogels Inc (ASPN) is now in the Fair zone, suggesting that its current forward PS ratio of 4.11 is considered Fairly compared with the five-year average of 17.32. The fair price of Aspen Aerogels Inc (ASPN) is between 1.86 to 6.25 according to relative valuation methord.
Relative Value
Fair Zone
1.86-6.25
Current Price:3.86
Fair
68.08
PE
1Y
3Y
5Y
Trailing
Forward
12.80
EV/EBITDA
Aspen Aerogels Inc. (ASPN) has a current EV/EBITDA of 12.80. The 5-year average EV/EBITDA is -14.06. The thresholds are as follows: Strongly Undervalued below -96.13, Undervalued between -96.13 and -55.10, Fairly Valued between 26.98 and -55.10, Overvalued between 26.98 and 68.02, and Strongly Overvalued above 68.02. The current Forward EV/EBITDA of 12.80 falls within the Historic Trend Line -Fairly Valued range.
61.59
EV/EBIT
Aspen Aerogels Inc. (ASPN) has a current EV/EBIT of 61.59. The 5-year average EV/EBIT is 1.78. The thresholds are as follows: Strongly Undervalued below -70.28, Undervalued between -70.28 and -34.25, Fairly Valued between 37.81 and -34.25, Overvalued between 37.81 and 73.85, and Strongly Overvalued above 73.85. The current Forward EV/EBIT of 61.59 falls within the Overvalued range.
3.86
PS
Aspen Aerogels Inc. (ASPN) has a current PS of 3.86. The 5-year average PS is 4.01. The thresholds are as follows: Strongly Undervalued below -1.84, Undervalued between -1.84 and 1.08, Fairly Valued between 6.93 and 1.08, Overvalued between 6.93 and 9.86, and Strongly Overvalued above 9.86. The current Forward PS of 3.86 falls within the Historic Trend Line -Fairly Valued range.
17.41
P/OCF
Aspen Aerogels Inc. (ASPN) has a current P/OCF of 17.41. The 5-year average P/OCF is -10.03. The thresholds are as follows: Strongly Undervalued below -90.79, Undervalued between -90.79 and -50.41, Fairly Valued between 30.35 and -50.41, Overvalued between 30.35 and 70.74, and Strongly Overvalued above 70.74. The current Forward P/OCF of 17.41 falls within the Historic Trend Line -Fairly Valued range.
23.17
P/FCF
Aspen Aerogels Inc. (ASPN) has a current P/FCF of 23.17. The 5-year average P/FCF is -1.05. The thresholds are as follows: Strongly Undervalued below -101.48, Undervalued between -101.48 and -51.27, Fairly Valued between 49.16 and -51.27, Overvalued between 49.16 and 99.37, and Strongly Overvalued above 99.37. The current Forward P/FCF of 23.17 falls within the Historic Trend Line -Fairly Valued range.
Aspen Aerogels Inc (ASPN) has a current Price-to-Book (P/B) ratio of 1.09. Compared to its 3-year average P/B ratio of 2.08 , the current P/B ratio is approximately -47.45% higher. Relative to its 5-year average P/B ratio of 4.17, the current P/B ratio is about -73.73% higher. Aspen Aerogels Inc (ASPN) has a Forward Free Cash Flow (FCF) yield of approximately 0.01%. Compared to its 3-year average FCF yield of -24.12%, the current FCF yield is approximately -100.03% lower. Relative to its 5-year average FCF yield of -17.77% , the current FCF yield is about -100.04% lower.
1.03
P/B
Median3y
2.08
Median5y
4.17
0.01
FCF Yield
Median3y
-24.12
Median5y
-17.77
Financial AI Agent

Competitors Valuation Multiple

The average P/S ratio for ASPN's competitors is 4.74, providing a benchmark for relative valuation. Aspen Aerogels Inc Corp (ASPN) exhibits a P/S ratio of 3.86, which is -18.54% above the industry average. Given its robust revenue growth of -37.77%, this premium appears unsustainable.
Intellectia AI SwingMax

Performance Decomposition

1Y
3Y
5Y
Market capitalization of ASPN decreased by 73.92% over the past 1 year. The primary factor behind the change was an increase in P/E Change from -1.17 to -1.00.
The secondary factor is the Margin Expansion, contributed -21.54%to the performance.
Overall, the performance of ASPN in the past 1 year is driven by P/E Change. Which is more unsustainable.
-37.77%
117.34M → 73.02M
Revenue Growth
+
-21.54%
-11.05 → -8.67
Margin Expansion
+
-14.61%
-1.17 → -1.00
P/E Change
=
-73.92%
14.80 → 3.86
Mkt Cap Growth

FAQ

arrow icon

Is Aspen Aerogels Inc (ASPN) currently overvalued or undervalued?

Aspen Aerogels Inc (ASPN) is now in the Fair zone, suggesting that its current forward PS ratio of 4.11 is considered Fairly compared with the five-year average of 17.32. The fair price of Aspen Aerogels Inc (ASPN) is between 1.86 to 6.25 according to relative valuation methord.
arrow icon

What is Aspen Aerogels Inc (ASPN) fair value?

arrow icon

How does ASPN's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for Aspen Aerogels Inc (ASPN) as of Nov 08 2025?

arrow icon

What is the current FCF Yield for Aspen Aerogels Inc (ASPN) as of Nov 08 2025?

arrow icon

What is the current Forward P/E ratio for Aspen Aerogels Inc (ASPN) as of Nov 08 2025?

arrow icon

What is the current Forward P/S ratio for Aspen Aerogels Inc (ASPN) as of Nov 08 2025?